Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

Outsourcing in Drug Discovery Report 2016 - Alliances Between The Pharmaceutical/Biotechnology Industries and Academia - Research and Markets
By: PR Newswire Association LLC. - 30 May 2016Back to overview list

 

 

 

 

DUBLIN, May 30, 2016
/PRNewswire/ --

Research and Markets has announced the addition of the "Outsourcing in Drug Discovery, 7th Edition" report to their offering.



The report also provides an overview of the CRO drug discovery process, and profiles of top competitors.

Outsourcing in Drug Discovery, provides details estimates and forecasts of the contract research organization market and an in depth look into the trends that have shaped the drug discovery outsourcing market today, and details the current and future global market. As part of its coverage, the report provides markets and forecasts for chemistry, biology and lead optimization.



This report covers the contract research organization (CRO) field.

Key Topics Covered:

CHAPTER ONE: EXECUTIVE SUMMARY


Pharmaceutical Industry Challenges
Reducing R&D Spending
Number of Nmes and Blas Approved Between 1993-2013
Source: Biolog, Inc. and Kalorama Information
Scope and Methodology
The Drug Discovery Process
Accelerating The Drug Discovery Process
Bottlenecks Within The Drug Discovery Process
Outsourcing to Increase Efficiency
Outsourcing Drug Discovery
The Outsourcing Decision
Developing An Outsourcing Plan
Contract Research Organizations
Strategic Versus Tactical Outsourcing Model
Effective Communication Is Essential
Mitigating The Challenges of Protecting IP Rights
offshoring Contract Drug Discovery
Factors to Consider In offshore Outsourcing
Benefits of Global Outsourcing
Cost Advantage
Concerns About Global Outsourcing
Outsourcing to China
Chinese Contract Research Organizations
FDA offices In China
Outsourcing to India
Drug Discovery Services In India
Outsourcing to Eastern Europe
Drug Discovery Outsourcing Market
Global Economic Downturn Has Minimal Affect On Drug Discovery

CHAPTER TWO: INTRODUCTION


Introduction to Outsourcing Drug Discovery
Developing An Outsourcing Plan
Factors to Consider In offshore Outsourcing
Benefits of Global Outsourcing
Cost Advantage
Access to Talent and Technologies
Compress Timeline
Increase Production
Concerns About Global Outsourcing
Intellectual Property Protection (IP)
Confidential Information and Trade Secrets
Fraud and Corruption
Meeting Regulatory Compliance Demands
Long Distance
Introduction
Choosing The Right CRO
Experience Is Paramount
Facility Standards
Excellent Track Record
Global Outsourcing

CHAPTER THREE: THE DRUG DISCOVERY PROCESS


The Drug Discovery Process
Introduction
Drug Discovery Stages
Target Identification
Target Validation
High Throughput Screening
Lead Optimization
Accelerating The Drug Discovery Process
Technologies Utilized In Drug Discovery
Combinatorial Chemistry
Bioinformatics/Pharmacogenomics
ADME/tox Screening
High Throughput Screening
Computational Modeling and Bioinformatics
Bottlenecks Within The Drug Discovery Process
Outsourcing to Increase Efficiency
Outsourcing to Access Novel Technologies
Bioinformatics
Lab-On-A-Chip: Microfluidics In Drug Discovery

CHAPTER FOUR: TRENDS


Trends In Outsourcing Drug Discovery
Overview
Is The Traditional Drug Discovery Model Changing?
Outsourcing Drug Discovery: A Useful Core Management tool
Contract Research Organizations
Introduction
Role of A CRO
Outsourcing Models
The Tactical Model
The Strategic Model
The Insourcing Model
Effective Communication Is Essential
for A Successful Partnership
Mitigating The Challenges of Protecting IP Rights
offshoring Contract Drug Discovery
Introduction
Robust Growth of Outsourcing Drug Discovery In Asia
Outsourcing to China
Introduction
Multi-National Pharmaceutical Companies Establish Research and Development
Facilities In China
Chinese Contract Research Organizations
Wuxi Apptec China's Largest CRO
First Chinese CRO Alliance
FDA offices In China
IP Rights Enforcement System
Outsourcing to India
Introduction
Drug Discovery Services In India
India's Handling of IP Rights and Laws
Patent Filing Considerations
Limitations On Patentability
Compulsory Licenses
FDA offices In India
Outsourcing to Eastern Europe
Introduction
Eastern European Cros

CHAPTER FIVE: MARKET ANALYSIS


Overview
Drug Discovery Outsourcing Market
Current Market and forecast
Market Analysis By Segment
Chemistry Services Market
Current Market and forecast
Biology Services Market
Current Market and forecast
High Throughput Screening Services Market
Current Market and forecast
Lead Optimization Services Market
Current Market and forecast
Contract Drug Discovery Competitors
Recent Acquisitions In Drug Discovery Outsourcing, 2014-2016
Alliances Between Academic Organizations and Cros
Alliances Between The Pharmaceutical/Biotechnology Industries and Academia
Alliances Between Cros
Market Growth Expanding Global Reach and Scale of Drug Discovery Services

CHAPTER SIX: COMPETITOR PROFILES

  • Albany Molecular Research, Inc.
  • Aptuit, LLC
  • Asinex Ltd.
  • Aurelia Bioscience Ltd
  • Axxam Spa
  • Bioduro
  • Charnwood Molecular
  • Chembridge Corp.
  • Chempartner Co.,Ltd.
  • Covance, Inc.
  • Creagen Biosciences, Inc.
  • Cyprotex PLC
  • Domainex
  • Emerald Biostructures
  • Enamine Ltd.
  • Evotec AG
  • Exelgen Discovery
  • GVK Biosciences Private Limited
  • Genscript USA Inc.
  • Griffinity Pharmaceuticals Gmbh
  • Hitgen, Ltd.
  • Hutchison Medipharma Ltd.
  • Jubilant Biosys Ltd
  • Nanosyn, Inc.
  • Pharmaron Inc.
  • Ricerca Biosciences, LLC
  • Selcia Limited
  • Selvita S.A.
  • Shanghai Medicilon Inc.
  • Sundia Meditech Company, LTD.
  • Sygnature Discovery Limited
  • TCG Lifesciences Limited
  • VIVA BIOTECH, LTD

For more information visit http://www.researchandmarkets.com/research/l2bp6j/outsourcing_in


Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

 


 

SOURCE Research and Markets

Related companies:Ascendiant Capital
Copyright 2016 PR Newswire Association LLC. Back to overview list
to the top ↑